Enorama Pharma AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0008216329
SEK
2.32
0.02 (0.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Enorama Pharma AB stock-summary
stock-summary
Enorama Pharma AB
Pharmaceuticals & Biotechnology
Enorama Pharma AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company is mainly focused on the development of medical chewing gum that contains drugs. The Company's product Nicotine gum is a chewing gum contained drugs that help to overcome nicotine addiction. In addition, the medical chewing gum applications include pain management, allergy, cough and cold, among others. The Company distributes its products in Europe through pharmacy chains and grocery stores.
Company Coordinates stock-summary
Company Details
Sodergatan 3 , MALMO None : 211 34
stock-summary
Tel: 46 08 51800051
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Anders Ermen
Chairman of the Board
Mr. Mats Ronngard
Chief Executive Officer, Director
Mr. Anders Dahlin
Director
Mr. Tomas Eriksson
Director
Mr. Bengt Jonsson
Director
Mr. Mats Persson
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-19 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 213 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.34

stock-summary
Return on Equity

955.09%

stock-summary
Price to Book

-28.86